This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
What's in Store for Intuitive Surgical's (ISRG) Q3 Earnings?
by Zacks Equity Research
Intuitive Surgical's (ISRG) third-quarter earnings are likely to reflect weaker-than-expected performance at Instruments & Accessories segment.
Robot-Assisted Surgery Gains Momentum Amid Coronavirus
by Trina Mukherjee
Let's keep a watch on potentially strong three MedTech stocks with respect to robotic-assisted surgery that have shown promise during the pandemic.
The Zacks Analyst Blog Highlights: Amazon, Medtronic, CME Group, Intuitive Surgical and Duke Energy
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Amazon, Medtronic, CME Group, Intuitive Surgical and Duke Energy
Top Research Reports for Amazon, Medtronic & CME
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Amazon.com (AMZN), Medtronic (MDT) and CME Group (CME).
Here's Why You Should Avoid Betting on Intuitive Surgical Now
by Zacks Equity Research
Intense competition in the global MedTech space and weak operational performance weighs on Intuitive Surgical (ISRG).
Nevro Bolsters Growth Prospects With New Manufacturing Plan
by Zacks Equity Research
Nevro (NVRO) commences plan for manufacturing operations in Costa Rica, thereby expanding its geographic footprint and boosting growth prospects.
Top Analyst Reports for Intel, Coca-Cola & Starbucks
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Intel (INTC), Coca-Cola (KO) and Starbucks (SBUX).
The Zacks Analyst Blog Highlights: Verizon Communications, Novartis, Abbott Laboratories, AT&T, Intuitive Surgical and Northrop Grumman
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Verizon Communications, Novartis, Abbott Laboratories, AT&T, Intuitive Surgical and Northrop Grumman
Top Stock Reports for Verizon, Novartis & Abbott
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Verizon Communications (VZ), Novartis (NVS) and Abbott Laboratories (ABT).
Here's Why You Should Hold on to Intuitive Surgical Stock Now
by Zacks Equity Research
Intuitive Surgical (ISRG) continues to benefit from rising da Vinci Surgical System, strong international presence and robust recurring revenue base.
Intuitive Surgical (ISRG) Q2 Earnings Top Estimates, Down Y/Y
by Zacks Equity Research
Intuitive Surgical's (ISRG) second-quarter results reflect weak performance across all businesses and lower revenues.
The 5 Hottest Earnings Charts This Week
by Tracey Ryniec
They're all hitting new all-time highs. But can they keep the sizzle after they report earnings?
What's in the Cards for Intuitive Surgical (ISRG) Q2 Earnings?
by Zacks Equity Research
Intuitive Surgical's (ISRG) second-quarter earnings are likely to reflect weaker-than-expected performance at Instruments & Accessories segment and decline in da Vince procedure volume.
Medical Products Industry's Near-Term Outlook Lacks Spark
by Trina Mukherjee
AI & Robotics can drive the medical products industry amid the coronavirus-induced crisis.
3 MedTech Stocks to Buy Amid Intensifying Coronavirus Fears
by Trina Mukherjee
Let's keep a watch on three stocks that have shown tremendous promise amid the pandemic.
Coronavirus Spurs Growth for 3 Robotics-Assisted Surgery Stocks
by Sriparna Ghosal
In the face of the pandemic, the robotics-assisted surgery space continues to thrive on a slew of positive developments.
Here's Why You Should Hold on to Intuitive Surgical Stock Now
by Zacks Equity Research
Intuitive Surgical (ISRG) continues to benefit from rising da Vinci Surgical System, strong international presence and robust recurring revenue base.
Intuitive Surgical (ISRG) Q1 Earnings Beat Estimates, Up Y/Y
by Zacks Equity Research
Intuitive Surgical (ISRG) first-quarter results benefit from strong growth across all businesses and higher revenues.
What's in Store for Intuitive Surgical (ISRG) Q1 Earnings?
by Zacks Equity Research
Intuitive Surgical's (ISRG) Q1 earnings are likely to reflect better-than-expected performance at Instruments & Accessories segment and da Vinci procedure growth.
Zacks Value Trader Highlights: eBay, Pfizer, JPMorgan Chase, Intuitive Surgical and Edwards Lifesciences
by Zacks Equity Research
Zacks Value Trader Highlights: eBay, Pfizer, JPMorgan Chase, Intuitive Surgical and Edwards Lifesciences
5 Superstar Stocks on Sale During the Coronavirus Crisis
by Tracey Ryniec
Stocks are the only thing people won't buy when they go on sale. But with stocks in a bear market, now's your chance to pick up some of the best companies.
Coronavirus Hits Elective Procedures: 3 MedTech Stocks to Avoid
by Trina Mukherjee
Amid the pandemonium on the account of coronavirus, we look into three stocks that have been struggling to cope with the scenario.
Here's Why You Should Invest in Intuitive Surgical Stock Now
by Zacks Equity Research
Intuitive Surgical (ISRG) continues to benefit from da Vinci surgical system, strong global foothold and solid recurring revenue base. However, stiff competition remains a woe.
Medical Products Industry Outlook: Growth Prospects Bright
by Trina Mukherjee
Growth prospects look bright for the Zacks Medical Products industry, courtesy of AI, Medical Mechatronics and Robotics and growing R&D expenditure.
Here's Why You Should Add HealthEquity (HQY) to Portfolio Now
by Zacks Equity Research
Solid prospects in the HSA industry consistently drive HealthEquity (HQY).